A recent study reveals that India is now among the top three most obese nations globally, with nearly 70% of the population falling into the overweight category.
The data shows a sharp rise in obesity rates over the years:
- Among women, obesity increased from 1.2% in 1990 to 9.8% in 2022
- Among men, it rose from 0.5% to 5.4% during the same period
These numbers highlight a growing public health concern and the urgent need for increased awareness and access to effective weight management solutions in the country. Source: IndiaTimes
Weight management has always been a challenge for millions of people. In India, where over 135 million people are estimated to be overweight or obese, the launch of Wegovy, a revolutionary weight loss injection, marks a major turning point in chronic obesity treatment. But as promising as it sounds, the real question many are asking is: how much does Wegovy actually cost in India?
Here we’ll cover everything from Wegovy’s price per injection to monthly treatment cost, dose-wise breakdowns, comparisons with competitors like Mounjaro, and its availability across India.
What is Wegovy (semaglutide)?
Wegovy (generic name: semaglutide) is a prescription-only injectable medication developed by Novo Nordisk. It’s the first and only FDA-approved weight management injection specifically formulated for chronic weight loss in people with obesity or weight-related health conditions.
How Wegovy Works
At its core, Wegovy mimics a hormone called GLP-1 (glucagon-like peptide-1), which targets areas of the brain that regulate appetite and food intake. It makes you feel full faster and for longer, helping you eat less without battling constant cravings.
Unlike traditional diet pills that often use stimulants or diuretics, Wegovy is scientifically designed to address obesity at the hormonal level. It’s injected once a week under the skin and comes in a pen-like device for self-administration. The dosing starts low and gradually increases over time to minimize side effects.
Approved Uses and Benefits
Wegovy isn’t just for cosmetic weight loss. It’s been approved for individuals who:
- Have a BMI ≥30 (obese), or
- Have a BMI ≥27 (overweight) with at least one weight-related health condition such as diabetes, high blood pressure, or high cholesterol
Some key benefits include:
- Sustainable Weight Loss: Clinical trials show up to 15-20% body weight reduction over 68 weeks
- Heart Health: Recently approved to reduce cardiovascular risk in overweight adults
- Appetite Control: Significant reduction in food intake and portion size
- Glucose Management: Beneficial for patients with type 2 diabetes
Wegovy Price & Dosage Strengths
Let’s cut to the chase: what does Wegovy cost in India?
Novo Nordisk has introduced a tiered dosing and pricing model, where the cost varies based on the dosage phase of the treatment. Here’s how it breaks down:
Dose-wise Breakdown
| Dose Tier | Dosage (mg/week) | Cost per Injection (₹) | Monthly Cost (₹) |
| Starting Dose | 0.25 – 1.0 mg | ₹4,336.25 | ₹17,345 |
| Intermediate | 1.7 mg | ₹6,070 | ₹24,280 |
| Full Dose | 2.4 mg | ₹6,503.75 | ₹26,015 – ₹26,050 |
The injection is administered once a week, meaning four injections per month. The full therapeutic dose of 2.4 mg is generally reached by the fifth or sixth month of treatment.
Monthly Treatment Cost
- Initial Phase (Month 1–2): You’ll start with lower doses (0.25-1 mg), so you’ll spend around ₹17,345/month.
- Middle Phase (Month 3–4): You may move up to 1.7 mg, increasing the cost to ₹24,280/month.
- Full Dose Phase (Month 5 onward): Most patients end up at 2.4 mg/week, costing ₹26,015/month.
These prices are MRP (Maximum Retail Price) and may vary slightly based on pharmacy and region.
Wegovy’s India Launch (June 2025)
In June 2025, Novo Nordisk officially launched Wegovy in India, creating a buzz in both healthcare and consumer circles. After success in the U.S. and Europe, the company is now targeting India’s growing urban population that is increasingly affected by obesity and lifestyle diseases.
Why Wegovy is Making Headlines
Wegovy is more than just a weight loss drug; it’s being hailed as a breakthrough in managing obesity as a chronic disease, not just a lifestyle issue. Its launch comes amid rising global demand for GLP-1 agonists, especially as celebrities and influencers bring these drugs into the public eye.
In India, this marks the first nationwide launch of an anti-obesity injection that combines both weight loss and cardiovascular benefits, according to reports by Business Standard and Reuters.
Comparison With Global Launch
Globally, Wegovy saw sky-high demand upon release, even leading to shortages in countries like the U.S. and the U.K. However, the Indian launch is relatively well-stocked, albeit priced on the premium side. The Indian version is manufactured in Denmark and distributed via Novo Nordisk India Ltd.
Compared to the U.S., where Wegovy can cost up to $1,350/month (approximately ₹112,000), the Indian pricing offers a substantial discount. This strategic pricing aims to gain traction among India’s emerging urban healthcare consumers while still preserving brand exclusivity.
Is Wegovy Available Over the Counter in India?
No, Wegovy is a prescription-only medicine in India. It must be prescribed by a qualified doctor, typically an endocrinologist, diabetologist, or weight management specialist. Self-medication is highly discouraged due to potential side effects, especially during the initial dose-escalation phase.
Where to Buy Wegovy in India
Wegovy is currently available at:
- Major pharmacy chains like Apollo, MedPlus, 1mg, and Netmeds
- Select online platforms with doctor e-prescriptions
- Novo Nordisk partner hospitals and clinics
It’s always best to go through a certified healthcare provider who can guide you on dosage, side effects, and lifestyle modifications for best results.
Mounjaro vs Wegovy vs Ozempic
Mounjaro (tirzepatide) by Eli Lilly is Wegovy’s biggest competitor in India, launched just a few months earlier. It also targets weight loss and diabetes management through a similar hormonal pathway.
- Mounjaro Cost: ₹14,000–₹17,500/month
- Wegovy Cost: ₹17,345–₹26,050/month
Wegovy is slightly more expensive but offers cardiovascular benefits in addition to weight loss, a feature not yet claimed by Mounjaro in India.
Ozempic and Other GLP-1 Agonists
Ozempic, also a semaglutide-based drug by Novo Nordisk, is used primarily for diabetes, not weight loss. However, some people use it off-label for obesity, often due to lower pricing.
- Ozempic Cost in India: Around ₹10,000/month
- But note: Ozempic is not approved for weight loss specifically and may not be covered under insurance for that purpose.
Side Effects and Safety Considerations
While Wegovy has been hailed as a “game-changer,” it’s not without side effects. Like all GLP-1 receptor agonists, it can cause:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Headaches
- Dizziness
In rare cases, more serious risks include:
- Pancreatitis
- Gallbladder problems
- Kidney issues
- Thyroid tumors (especially in those with a family history of medullary thyroid carcinoma)
That’s why dose titration (starting low and increasing gradually) is important. Most side effects are manageable and tend to diminish after the first few weeks.
Final Conclusion:
Wegovy has undoubtedly brought a new wave of hope for individuals struggling with obesity in India. With its scientifically backed weight loss capabilities, cardiovascular protection, and appetite control, it’s a game-changer in the fight against chronic weight-related illnesses. However, its premium price tag, ranging from ₹17,000 to over ₹26,000 per month, poses a real challenge for affordability.
FAQs
Ques 1. Is Wegovy available without a prescription in India?
Ans: No. Wegovy is strictly a prescription-only drug in India. You must consult a certified healthcare professional, such as an endocrinologist or obesity specialist, to obtain a prescription.
Ques 2. How soon can I expect results after starting Wegovy?
Ans: Most people begin noticing reduced appetite within the first 2-4 weeks. Significant weight loss usually starts around the 2nd or 3rd month as the dose increases. On average, clinical trials show a 15%–20% weight loss over 12–16 months when combined with diet and lifestyle changes.
Ques 3. Can Wegovy be used for weight loss in people without diabetes?
Ans: Yes. Wegovy is approved for weight loss in individuals with a BMI of 30 or more (obese) or a BMI of 27 or more with at least one weight-related health condition.
Ques 4. Is Wegovy covered by insurance in India?
Ans: No, most Indian insurance companies do not cover Wegovy injections.
Ques 5. When will cheaper alternatives to Wegovy be available in India?
Ans: Cheaper generic versions or biosimilars of Wegovy are expected to arrive after its patent expires, which is projected for 2026–2027.
